
Resources
Here you will find a range of media specific resources including our latest and archived press releases, and our photo and video library.
Media resources

Press releases
- Local budding biologists explore the past, present and future during GSK Science in the Summer™ in partnership with the Franklin Institute
- GSK delivers strong Q1 2022 sales of £9.8 billion, +32% AER, +32% CER; Total EPS 35.9p +67% AER, +66% CER and Adjusted EPS 32.8p +43% AER, +43% CER
- US Food and Drug Administration accepts New Drug Application for daprodustat
- GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
- New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+
GSK US on Twitter
-
GSKUS @GSKUS
This #AsthmaAwarenessMonth, we are highlighting the importance of discussing the full impact of asthma symptoms. If you have more questions after speaking to your doctor, consider working with a health educator to gain more understanding. @BREATHESOCAL
about 2 days ago -
GSKUS @GSKUS
#LupusAwarenessMonth is a time to educate and empower the #lupus community. We are proud partners of @LupusOrg as we continue to raise awareness of this chronic disease. Together, our shared ambition can make a difference in millions of lives impacted by lupus.
about 4 days ago
Media links
-
Media
Explore the latest news, different ways to stay in touch and available useful resources
-
Press releases
Keep up to date with our news and recent announcements
-
About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
-
Media contacts
Media contact details for the US